Logo

Naproxen Twice Daily Versus as Needed (PRN) Dosing: Efficacy and Tolerability for Treatment of Acute Ankle Sprain, a Randomized Clinical Trial

Author(s):
Majid HajimaghsoudiMajid Hajimaghsoudi1, Mohammad JaliliMohammad JaliliMohammad Jalili ORCID2,*, Mehdi MokhtariMehdi Mokhtari3, Amir NejatiAmir Nejati2, Javad MesbahiJavad Mesbahi2, Koosha PaydaryKoosha Paydary4
1Emergency Medicine Department, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2Emergency Medicine Department, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
3Department of Epidemiology, Urmia University of Medical Sciences, Urmia, Iran
4Students Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran


Asian Journal of Sports Medicine:Vol. 4, issue 4; 249-255
Published online:Aug 01, 2013
Article type:Research Article
Received:Mar 30, 2013
Accepted:Jul 15, 2013
How to Cite:Majid HajimaghsoudiMohammad JaliliMehdi MokhtariAmir NejatiJavad MesbahiKoosha Paydaryet al.Naproxen Twice Daily Versus as Needed (PRN) Dosing: Efficacy and Tolerability for Treatment of Acute Ankle Sprain, a Randomized Clinical Trial.Asian J Sports Med.4(4):34243.https://doi.org/10.5812/asjsm.11411.

Abstract

Purpose:

This study was conducted to compare the efficacy and safety of naproxen 500 mg twice daily (BID) versus naproxen 500 mg as needed (PRN) for treatment of ankle sprain.

Methods:

In this seven-day, randomized, parallel group trial, 135 patients with ankle sprain occurring less than 48 hours prior to the first dose of study medication were randomized to receive naproxen 500 mg BID (67 patients) and naproxen 500 mg as needed (PRN) (68 patients). The ankle pain was assessed at rest and on full weight bearing using Numeric Rating Scale (NRS) from 0 (no pain) to 10 (the worst imaginable pain). Ankle swelling was assessed as a 4-point scale ranging from 0 (no swelling) to 3 (severe swelling) rated by the investigator. The primary efficacy end point was the patient's assessment of ankle pain via NRS and the degree of swelling on day seven.

Results:

Results showed a significant decrease in pain on weight bearing, pain at rest and the extent of swelling (P<0.001) in both groups, but there was no substantial difference between the two groups (P>0.05) after seven days. Assessing the safety profile of the two different dosing, 13.3% of the naproxen BID group and 6.7% of the as needed group had adverse events, showing that the as needed regimen was safer (P<0.001).

Conclusion:

Results showed that naproxen as needed may reduce the pain and edema of the sprained ankle with no significant difference compared to the BID regimen, while it possesses better safety profile and lower total drug use.

Full Text

Full text is available in PDF

comments

Leave a comment here


Crossmark
Crossmark
Checking
Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles